Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol

Table 1

Baseline characteristics of the patients.

Baseline	1+PRN group	3+PRN group
Number (eyes)	57	38	NA
Age (years)
Gender (men/women)	34/23	24/14
HbA1c (%)
BCVA (logMAR)
CMT (μm)

BCVA: best-corrected visual acuity; CMT: central macular thickness; logMAR: logarithm of the minimum angle of resolution.